Atara Biotherapeutics Announces Board Transition, Welcomes Veteran Investor Brian Cherry as Director Atara Biotherapeutics, Inc., a clinical-stage biotechnology company focused on advancing T-cell immunotherapies for cancer and autoimmune diseases, has announced a significant change to its Board of Directors. The…
Xeris Receives USPTO Notice of Allowance for New Patent Covering KEVEYIS®, Extending Potential Protection Through 2039 Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdings, Inc., has announced a significant intellectual property milestone for KEVEYIS® (dichlorphenamide), its FDA-approved treatment…
Zetagen Therapeutics Reports Promising Phase 2a Results for Investigational ZetaMet™ in Metastatic Breast Cancer Patients With Lytic Bone Lesions Zetagen Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative therapies for primary and metastatic breast cancer, has released updated preliminary…
GENESIS Pharma and Alnylam Expand Strategic Partnership to Bring RNAi Therapies to Nordic Markets GENESIS Pharma has announced a significant expansion of its long-standing collaboration with Alnylam Pharmaceuticals, further strengthening the relationship between the two companies and broadening patient access…
Poxel Appoints Yves Decadt as Chief Executive Officer to Lead Next Phase of Growth and Strategic Development French biopharmaceutical company Poxel has announced the appointment of Yves Decadt as its new Chief Executive Officer, effective June 10, 2026. The leadership…
OpenEvidence and the American Academy of Ophthalmology Partner to Bridge the Gap Between Evidence and Clinical Eye Care American Academy of Ophthalmology, the world’s largest association of eye physicians and surgeons, has announced a strategic partnership with OpenEvidence to integrate…
Wisp Partners With Mount Sinai to Broaden Access to PrEP and HIV Prevention Services Across New York State Wisp, the largest pure-play women’s telehealth provider in the United States, has announced a strategic collaboration with the Mount Sinai Health System…
North Shore University Hospital Device Accelerates Ventilator Weaning in Patients A critically ill patient at Northwell Health’s North Shore University Hospital (NSUH) has become one of the first patients in the United States—and the first on the East Coast—to be…
Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Advance Its Path Toward Commercialization Neuraptive Therapeutics has announced two key leadership appointments aimed at strengthening both its corporate governance and financial infrastructure as the company advances its development pipeline focused on…
WuXi Biologics Singapore CRDMO Hub Achieves Modular Topping-Out of Drug Product Facility WuXi Biologics (2269.HK), a global leader in Contract Research, Development and Manufacturing Organization (CRDMO) services, has announced the completion of the topping out ceremony for its Drug Product…
CicadaBio to Present CC-18, a Novel GLP-1/ActRII Fusion Protein for Muscle-Sparing Weight Loss, at ADA 2026 CicadaBio has announced new preclinical findings for CC-18, its investigational dual-pathway fusion protein targeting both the GLP-1 receptor and the activin type II receptor…
LivaNova Names Anne Liddy as Chief Legal Officer LivaNova PLC, a global medical technology company specializing in advanced therapeutic solutions, has announced the appointment of Anne Liddy as its new Chief Legal Officer, effective August 31. In this role, she…